EXPECTORANT SYMPTOMATIC TREATMENT

Brand Owner Address Description
BRONKI BARTOLOMEI, ALBERTO S. Gurabo Industrial Park P.O. BOX 1360 Gurabo 00778 Puerto Rico EXPECTORANT IN THE SYMPTOMATIC TREATMENT OF CHRONIC PULMONARY DISEASES WHERE TENACIOUS MUCUS COMPLICATES THE PROBLEM, INCLUDING BRONCHIAL ASTHMA, BRONCHITIS AND PULMONARY EMPHYSEMA, IN THE FORM OF LIQUID, TABLETS, CAPSULE AND INJECTABLE;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.